Transferrin receptor 2 is a potential novel therapeutic target for β-thalassemia: evidence from a murine model

β-thalassemias are genetic disorders characterized by anemia, ineffective erythropoiesis, and iron overload. Current treatment of severe cases is based on blood transfusion and iron chelation or allogeneic bone marrow (BM) transplantation. Novel approaches are explored for nontransfusion-dependent p...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Blood
Päätekijät: Artuso, Irene, Lidonnici, Maria Rosa, Altamura, Sandro, Mandelli, Giacomo, Pettinato, Mariateresa, Muckenthaler, Martina U., Silvestri, Laura, Ferrari, Giuliana, Camaschella, Clara, Nai, Antonella
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Hematology 2018
Aiheet:
Red Cells, Iron, and Erythropoiesis
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6302281/
https://ncbi.nlm.nih.gov/pubmed/30209118
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2018-05-852277
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia